Step-by-Step Approach for Febrile Infants

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۹۰ • واحد: days

حداقل ۰ — حداکثر ۱۰۰ • واحد: ng/mL

حداقل ۰ — حداکثر ۵۰۰ • واحد: mg/L

حداقل ۰ — حداکثر ۱۰۰۰۰۰ • واحد: /mm³

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
risk class
—class
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low risk0–0
  • Not low risk1–1
Direct Clinical Answer

The Step-by-Step Approach for Febrile Infants calculates calculating weight-based pediatric dosing and evaluating age-specific physiological parameters. Key inputs include ill appearing. Scores guide titrating weight-adjusted medication dosing, monitoring developmental safety, and evaluating treatment response. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Step-by-Step approach (Gomez 2016) to identify febrile infants ≤90 days at low risk of invasive bacterial infection (bacteremia/meningitis). Sequential rule: ill appearance, age ≤21 days, leukocyturia, procalcitonin ≥0.5 ng/mL, or CRP >20 mg/L / ANC >10,000 per mm³ each classify the infant as NOT low risk; otherwise low risk.

Clinical Indication

The Step-by-Step Approach for Febrile Infants is indicated for bedside clinical practice to support Step-by-Step approach (Gomez 2016) to identify febrile infants ≤90 days at low risk of invasive bacterial infection (bacteremia/meningitis). Sequential rule: ill appearance, age ≤21 days, leukocyturia, procalcitonin ≥0.5 ng/mL, or CRP >20 mg/L / ANC >10,000 per mm³ each classify the infant as NOT low risk; otherwise low risk.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Neonates, infants, children, and adolescents from birth up to 18 years of age. Clinical application is indicated across Pediatric emergency departments, pediatric inpatient wards, PICU, and pediatric primary care.

Limitations & Contraindications

Adult scoring thresholds and pharmacological formulas must never be applied to pediatric patients. Clinical exclusion: Applies ONLY to well-defined population: febrile infants ≤90 days old without an evident source; excludes preterm, ill-defined, or previously treated infants per the original study criteria..

Clinical Pearls & Action Plan

Accurate weight-based dosing and age-stratified physiological vital sign reference ranges are foundational in pediatric clinical practice. Guideline pearl: Original validation: Gomez B et al. Pediatrics. 2016;138(2):e20154381..

Formula & Variables:

Sequential: ill-appearing? -> not low risk | age <= 21d? -> not low risk | leukocyturia? -> not low risk | procalcitonin >= 0.5? -> not low risk | CRP > 20 or ANC > 10000? -> not low risk | else LOW RISK

Input Parameters

NameTypeRequiredDescription
ill_appearingstringYesInfant appears ill on examination
age_daysintegerYesAge in days (must be ≤90 for this approach)(days)
leukocyturiastringYesLeukocyturia on urine dipstick/urinalysis
procalcitoninfloatYesSerum procalcitonin(ng/mL)
crpfloatYesC-reactive protein(mg/L)
ancfloatYesAbsolute neutrophil count(/mm³)

Score Interpretation & Guidance

RangeStageDescription
0–0Low riskLow risk of invasive bacterial infection
1–1Not low riskNot low risk - requires full evaluation

Evidence-Based References (EBM)

  • Gomez B, Mintegi S, Bressan S, et al. Validation of the 'Step-by-Step' Approach in the Management of Young Febrile Infants. Pediatrics. 2016;138(2):e20154381.

Related calculators